Issue navigation
Volume 60, Issue 3, March 2021
EDITORIALS
What is remission in gout and how should we measure it?
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1007–1009, https://doi.org/10.1093/rheumatology/keaa853
Maintenance rituximab treatment for ANCA-associated vasculitis: to be continued?
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1010–1012, https://doi.org/10.1093/rheumatology/keaa812
Facing the challenges of running a rheumatology-based ultrasound service in the COVID-19 era
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1013–1015, https://doi.org/10.1093/rheumatology/keaa844
REVIEW ARTICLES
New insights into the role of imaging in polymyalgia rheumatica
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1016–1033, https://doi.org/10.1093/rheumatology/keaa646
What’s new in ocular and oral aspects of Sjögren’s syndrome and do new treatments work?
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1034–1041, https://doi.org/10.1093/rheumatology/keaa854
The role of inflammation in mesenchymal stromal cell therapy in osteoarthritis, perspectives for post-traumatic osteoarthritis: a review
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1042–1053, https://doi.org/10.1093/rheumatology/keaa910
SYSTEMATIC REVIEW AND META-ANALYSIS
The oral and gut microbiome in rheumatoid arthritis patients: a systematic review
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1054–1066, https://doi.org/10.1093/rheumatology/keaa835
Prevalence and risk factors of relapse in patients with ANCA-associated vasculitis receiving cyclophosphamide induction: a systematic review and meta-analysis of large observational studies
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1067–1079, https://doi.org/10.1093/rheumatology/keaa667
Prognostic factors for finger interphalangeal joint osteoarthritis: a systematic review
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1080–1090, https://doi.org/10.1093/rheumatology/keaa735
Socioeconomic status and occurrence of chronic pain: a meta-analysis
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1091–1105, https://doi.org/10.1093/rheumatology/keaa758
Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1106–1113, https://doi.org/10.1093/rheumatology/kez596
CLINICAL SCIENCE
EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1114–1124, https://doi.org/10.1093/rheumatology/keaa203
Axial and peripheral spondyloarthritis: does psoriasis influence the clinical expression and disease burden? Data from REGISPONSER registry
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1125–1136, https://doi.org/10.1093/rheumatology/keaa398
Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1137–1147, https://doi.org/10.1093/rheumatology/keaa271
Maternal and foetal placental vascular malperfusion in pregnancies with anti-phospholipid antibodies
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1148–1157, https://doi.org/10.1093/rheumatology/keaa499
Ruling out septic arthritis risk in a few minutes using mid-infrared spectroscopy in synovial fluids
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1158–1165, https://doi.org/10.1093/rheumatology/keaa373
Identification and characterization of two consistent osteoarthritis subtypes by transcriptome and clinical data integration
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1166–1175, https://doi.org/10.1093/rheumatology/keaa391
Distal phalangeal bone erosions observed by HR-pQCT in patients with psoriatic onycholysis
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1176–1184, https://doi.org/10.1093/rheumatology/keaa415
Changes in bone formation regulator biomarkers in early axial spondyloarthritis
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1185–1194, https://doi.org/10.1093/rheumatology/keaa296
Prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease: a retrospective study of 679 adult cases
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1195–1204, https://doi.org/10.1093/rheumatology/keaa372
Variation in the pharmacokinetics of glucosamine in healthy individuals
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1205–1209, https://doi.org/10.1093/rheumatology/keaa418
Highly sensitive serum cardiac troponin T and cardiovascular events in patients with systemic lupus erythematosus (TROPOPLUS study)
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1210–1215, https://doi.org/10.1093/rheumatology/keaa434
Muscle deterioration due to rheumatoid arthritis: assessment by quantitative MRI and strength testing
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1216–1225, https://doi.org/10.1093/rheumatology/keaa364
Efficacy and serious adverse events profile of the adjuvanted recombinant zoster vaccine in adults with pre-existing potential immune-mediated diseases: a pooled post hoc analysis on two parallel randomized trials
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1226–1233, https://doi.org/10.1093/rheumatology/keaa424
Long-term efficacy of adding intravenous immunoglobulins as treatment of refractory dysphagia related to myositis: a retrospective analysis
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1234–1242, https://doi.org/10.1093/rheumatology/keaa443
Epidemiologic study of patients with psoriatic arthritis in a real-world analysis: a cohort study of the French health insurance database
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1243–1251, https://doi.org/10.1093/rheumatology/keaa448
Untargeted lipidomics reveals specific lipid abnormalities in Sjögren’s syndrome
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1252–1259, https://doi.org/10.1093/rheumatology/keaa456
Impact of overweight and obesity on patient-reported health-related quality of life in systemic lupus erythematosus
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1260–1272, https://doi.org/10.1093/rheumatology/keaa453
Association of altered folylpolyglutamate synthetase pre-mRNA splicing with methotrexate unresponsiveness in early rheumatoid arthritis
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1273–1281, https://doi.org/10.1093/rheumatology/keaa428
Ultrasound-guided core needle biopsy compared with open biopsy: a new diagnostic approach to salivary gland enlargement in Sjögren’s syndrome?
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1282–1290, https://doi.org/10.1093/rheumatology/keaa441
The association between psychological factors and pain exacerbations in hip osteoarthritis
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1291–1299, https://doi.org/10.1093/rheumatology/keaa494
Possible misclassification of cardiovascular risk by SCORE in antisynthetase syndrome: results of the pilot multicenter study RI.CAR.D.A
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1300–1312, https://doi.org/10.1093/rheumatology/keaa525
Prevalence, outcome and management of patients with SLE and secondary antiphospholipid antibody syndrome after aPL seroconversion
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1313–1320, https://doi.org/10.1093/rheumatology/keaa463
Systemic autoimmune disease as a cause of death: mortality burden and comorbidities
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1321–1330, https://doi.org/10.1093/rheumatology/keaa537
Morbidity and mortality in antiphospholipid syndrome based on cluster analysis: a 10-year longitudinal cohort study
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1331–1337, https://doi.org/10.1093/rheumatology/keaa542
Power and spectral Doppler ultrasound in suspected active sacroiliitis: a comparison with magnetic resonance imaging as gold standard
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1338–1345, https://doi.org/10.1093/rheumatology/keaa546
The cut-off values for the intima–media complex thickness assessed by colour Doppler sonography in seven cranial and aortic arch arteries
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1346–1352, https://doi.org/10.1093/rheumatology/keaa578
Sialendoscopy increases saliva secretion and reduces xerostomia up to 60 weeks in Sjögren’s syndrome patients: a randomized controlled study
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1353–1363, https://doi.org/10.1093/rheumatology/keaa284
A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren’s syndrome
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1364–1375, https://doi.org/10.1093/rheumatology/keaa410
Anti-protein C antibodies and acquired protein C resistance in SLE: novel markers for thromboembolic events and disease activity?
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1376–1386, https://doi.org/10.1093/rheumatology/keaa509
Mycophenolate mofetil for methotrexate-resistant juvenile localized scleroderma
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1387–1391, https://doi.org/10.1093/rheumatology/keaa392
Association between meniscal volume and development of knee osteoarthritis
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1392–1399, https://doi.org/10.1093/rheumatology/keaa522
Cardiovascular risk and mortality in rheumatoid arthritis compared with diabetes mellitus and the general population
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1400–1409, https://doi.org/10.1093/rheumatology/keaa374
Reporting items for capillaroscopy in clinical research on musculoskeletal diseases: a systematic review and international Delphi consensus
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1410–1418, https://doi.org/10.1093/rheumatology/keaa457
Anti-carbamylated protein antibodies in premenopausal rheumatoid arthritis women: relation to disease activity and bone loss
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1419–1428, https://doi.org/10.1093/rheumatology/keaa549
Systemic vascular distensibility relates to exercise capacity in connective tissue disease
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1429–1434, https://doi.org/10.1093/rheumatology/keaa510
Sustained-release diclofenac conjugated to hyaluronate (diclofenac etalhyaluronate) for knee osteoarthritis: a randomized phase 2 study
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1435–1444, https://doi.org/10.1093/rheumatology/keaa605
Interferon activation status underlies higher antibody response to viral antigens in patients with systemic lupus erythematosus receiving no or light treatment
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1445–1455, https://doi.org/10.1093/rheumatology/keaa611
Acquired low immunoglobulin levels and risk of clinically relevant infection in adult patients with systemic lupus erythematosus: a cohort study
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1456–1464, https://doi.org/10.1093/rheumatology/keaa641
Construct validity of the ASAS health index in psoriatic arthritis: a cross-sectional analysis
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1465–1473, https://doi.org/10.1093/rheumatology/keaa626
Estimation of the burden of shielding among a cross-section of patients attending rheumatology clinics with SLE—data from the BSR audit of systemic lupus erythematosus
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1474–1479, https://doi.org/10.1093/rheumatology/keaa620
BSR guideline on the management of adults with systemic lupus erythematosus (SLE) 2018: baseline multi-centre audit in the UK
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1480–1490, https://doi.org/10.1093/rheumatology/keaa759
Long-term maintenance rituximab for ANCA-associated vasculitis: relapse and infection prediction models
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1491–1501, https://doi.org/10.1093/rheumatology/keaa541
BASIC AND TRANSLATIONAL SCIENCE
Long-term systemic glucocorticoid therapy and weight gain: a population-based cohort study
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1502–1511, https://doi.org/10.1093/rheumatology/keaa289
Study of miRNA interactome in active rheumatoid arthritis patients reveals key pathogenic roles of dysbiosis in the infection–immune network
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1512–1522, https://doi.org/10.1093/rheumatology/keaa369
Otological aspects of NLRP3-related autoinflammatory disorder focusing on the responsiveness to anakinra
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1523–1532, https://doi.org/10.1093/rheumatology/keaa511
Dendritic cell integrin expression patterns regulate inflammation in the rheumatoid arthritis joint
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1533–1542, https://doi.org/10.1093/rheumatology/keaa686
Distinguishing lupus lymphadenitis from Kikuchi disease based on clinicopathological features and C4d immunohistochemistry
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1543–1552, https://doi.org/10.1093/rheumatology/keaa524
Imbalance toward TFH 1 cells playing a role in aberrant B cell differentiation in systemic sclerosis
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1553–1562, https://doi.org/10.1093/rheumatology/keaa669
LETTERS TO THE EDITOR
OTHERS
Could we measure hair colchicine to assess colchicine observance in familial Mediterranean fever?
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1563–1564, https://doi.org/10.1093/rheumatology/keaa811
Disease progression in systemic sclerosis
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1565–1567, https://doi.org/10.1093/rheumatology/keaa911
CLINICAL VIGNETTES
A clue for eosinophilic fasciitis: groove sign
Rheumatology, Volume 60, Issue 3, March 2021, Page 1113, https://doi.org/10.1093/rheumatology/keaa556
Periorbital purpura of AL amyloidosis
Rheumatology, Volume 60, Issue 3, March 2021, Page 1165, https://doi.org/10.1093/rheumatology/keaa545
Strawberry gums as an initial presentation of severe granulomatosis with polyangiitis
Rheumatology, Volume 60, Issue 3, March 2021, Page 1568, https://doi.org/10.1093/rheumatology/keaa601
Scalp calcinosis in juvenile dermatomyositis
Rheumatology, Volume 60, Issue 3, March 2021, Page 1569, https://doi.org/10.1093/rheumatology/keaa566
Palisaded neutrophilic and granulomatous dermatitis in a patient with rheumatoid arthritis
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1570–1571, https://doi.org/10.1093/rheumatology/keaa288
Headache in lupus: look for dense clot and empty delta signs
Rheumatology, Volume 60, Issue 3, March 2021, Page 1572, https://doi.org/10.1093/rheumatology/keaa482
Painful erythematoviolaceous nodules in dermatomyositis
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1573–1574, https://doi.org/10.1093/rheumatology/keaa455
Erratum
Erratum to: Interferon activation status underlies higher antibody response to viral antigens in patients with systemic lupus erythematosus receiving no or light treatment
Rheumatology, Volume 60, Issue 3, March 2021, Page 1575, https://doi.org/10.1093/rheumatology/keaa867
PUBLISHED ONLINE ONLY
CASE REPORTS
WT1 gene mutations in systemic lupus erythematosus with atypical haemolytic uremic syndrome
Rheumatology, Volume 60, Issue 3, March 2021, Pages e81–e82, https://doi.org/10.1093/rheumatology/keaa474
Acute pancreatitis: an atypical presentation of granulomatosis with polyangiitis
Rheumatology, Volume 60, Issue 3, March 2021, Pages e83–e84, https://doi.org/10.1093/rheumatology/keaa513
A unique case of co-existent sarcoidosis and immune-mediated necrotizing myopathy
Rheumatology, Volume 60, Issue 3, March 2021, Pages e85–e86, https://doi.org/10.1093/rheumatology/keaa530
Inflammatory aortitis in a patient with type 2 hyper IgM syndrome
Rheumatology, Volume 60, Issue 3, March 2021, Pages e87–e89, https://doi.org/10.1093/rheumatology/keaa573
Multiple tooth extractions triggering Behçet’s disease
Rheumatology, Volume 60, Issue 3, March 2021, Pages e90–e91, https://doi.org/10.1093/rheumatology/keaa479
NeMO mutations: a rare cause of monogenic Behçet-like disease
Rheumatology, Volume 60, Issue 3, March 2021, Pages e92–e94, https://doi.org/10.1093/rheumatology/keaa505
A possible association of orthopedic metal implants and ASIA syndrome
Rheumatology, Volume 60, Issue 3, March 2021, Pages e95–e96, https://doi.org/10.1093/rheumatology/keaa481
Amyloid A amyloidosis secondary to immunoglobulin G4–related disease
Rheumatology, Volume 60, Issue 3, March 2021, Pages e97–e98, https://doi.org/10.1093/rheumatology/keaa467
Secukinumab-induced scleroderma: a case report
Rheumatology, Volume 60, Issue 3, March 2021, Pages e99–e100, https://doi.org/10.1093/rheumatology/keaa603
Cutaneous IgA vasculitis—presenting manifestation of a novel mutation in the IKZF1 gene
Rheumatology, Volume 60, Issue 3, March 2021, Pages e101–e103, https://doi.org/10.1093/rheumatology/keaa492
Anti-MDA5 antibody–positive dermatomyositis with rapidly progressive interstitial lung disease disguising as anti-synthetase syndrome
Rheumatology, Volume 60, Issue 3, March 2021, Pages e104–e106, https://doi.org/10.1093/rheumatology/keaa507
Ultrasound in the diagnosis and monitoring of eosinophilic fasciitis
Rheumatology, Volume 60, Issue 3, March 2021, Pages e107–e108, https://doi.org/10.1093/rheumatology/keaa498
MATTERS ARISING
Comment on: EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies
Rheumatology, Volume 60, Issue 3, March 2021, Page e109, https://doi.org/10.1093/rheumatology/keaa533
Comment on: EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies: reply
Rheumatology, Volume 60, Issue 3, March 2021, Pages e110–e112, https://doi.org/10.1093/rheumatology/keaa539
Comment on: Prevalence, outcome and management of patients with SLE and secondary antiphospholipid antibody syndrome after aPL seroconversion
Rheumatology, Volume 60, Issue 3, March 2021, Pages e113–e114, https://doi.org/10.1093/rheumatology/keaa839
Comment on: Prevalence, outcome and management of patients with SLE and secondary antiphospholipid antibody syndrome after aPL seroconversion: reply
Rheumatology, Volume 60, Issue 3, March 2021, Pages e115–e117, https://doi.org/10.1093/rheumatology/keaa800
Comment on: Prevalence of systemic lupus erythematosus in Spain: higher than previously reported in other countries?
Rheumatology, Volume 60, Issue 3, March 2021, Pages e118–e119, https://doi.org/10.1093/rheumatology/keaa709
Comment on: Prevalence of systemic lupus erythematosus in Spain: higher than previously reported in other countries? Reply
Rheumatology, Volume 60, Issue 3, March 2021, Pages e120–e121, https://doi.org/10.1093/rheumatology/keaa762
